Miscellaneous antivirals

Sunlenca 463.5 mg/1.5 mL (309 mg/mL) injection Images

Generic Name: lenacapavir

This medication has been identified as Sunlenca 463.5 mg/1.5 mL (309 mg/mL) injection. It is supplied by Gilead Sciences, Inc.

Sunlenca is used in the treatment of HIV Infection and belongs to the drug class miscellaneous antivirals. Sunlenca 463.5 mg/1.5 mL (309 mg/mL) injection is not a controlled substance under the Controlled Substances Act (CSA).

Images

Sunlenca (oral/injection) (Lenacapavir (oral/injection))-medicine-463.5 mg/1.5 mL (309 mg/mL) injection

Sunlenca (oral/injection)
Generic Name: lenacapavir (oral/injection)
Imprint: medicine
Strength: 463.5 mg/1.5 mL (309 mg/mL) injection
Color: N/A
Size: N/A
Shape: N/A
Availability: Prescription only
Drug Class: Miscellaneous antivirals
Pregnancy Category: N/A
CSA Schedule: Not a controlled drug
Labeler / Supplier: N/A
National Drug Code (NDC): 61958-3002
Inactive Ingredients:
Latest News
Related Drugs